LIGHT is an immune - stimulating chemical messenger previously found to have low levels of expression in patients with colon cancer metastases. (sciencedaily.com)
«Patients with colon cancer lacking in AIM2 have been found to have poor survival, but we have identified a possible personalized therapeutic strategy to help them,» said Jenny Ting, William R. Kenan Jr.. (sciencedaily.com)
«For most patients with colon cancer that has spread to the liver, current treatments are palliative and not curative,» says Dr. Ajay Maker, associate professor of surgery in the UIC College of Medicine and corresponding author on the paper. (sciencedaily.com)